Trillium Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Trillium Asset Management's EXAS Position: Q1 2026 in Review
Trillium Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 43,760 shares — an estimated $4.62M sold.
Trillium Asset Management first reported a position in EXAS in Q2 2021 and held it in 9 quarters. The position peaked at $6.14M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Trillium Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Trillium Asset Management sold 43,760 Exact Sciences shares in Q1 2026, an estimated $4.62M.
- Trillium Asset Management first reported a position in Exact Sciences in Q2 2021 and held it in 9 quarters.
- Trillium Asset Management's Exact Sciences position peaked at $6.14M in Q2 2021.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Trillium Asset Management's 13F filing for Q1 2026, filed 11 May 2026.